Clinical Trial to Compare the PK of the Fixed-dose Combinations and Each Component of Gemigliptin/Dapagliflozin 50/10 mg

NCT04544319 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

T2DM

Interventions

DRUG: Zemiglo 50mg and Forxiga 10mg
DRUG: Fixed-dose Combinations of Gemigliptin/Dapagliflozin 50/10 mg

Sponsor

LG Chem